Private Equity Firm Cuts Stake in Brenntag Again

Brachem Acquisition, controlled by private equity firm BC Partners--the largest shareholder in Brenntag--has placed an additional 7 million Brenntag shares with institutional investors in an accelerated bookbuilding process. The stock was placed at a price of €71.50/share, valuing the 7 million shares at more than €500 million. The sale increases the portion of Brenntag listed on the Frankfurt Stock Exchange to almost 64%. The shares were placed by Goldman Sachs International. It is the second placement by Brachem since Brenntag's initial public...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers